12:00 AM
 | 
Oct 07, 2013
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Atossa Genetics sales and marketing update

Atossa is recalling its Mammary Aspirate Specimen Cytology Test (MASCT) device and the accompanying ForeCYTE Breast Health Test. The device is cleared for use only as a device to non-invasively collect samples of breast fluid. The specimens are analyzed at Atossa's CLIA-certified...

Read the full 197 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >